植入前遗传学检测与单胎及多胎妊娠母婴结局的关联:系统综述与荟萃分析
该系统综述与荟萃分析纳入42项研究(PGT组43 663例,IVF/ICSI组217 002例),比较PGT与IVF/ICSI受孕后单胎和多胎妊娠的母婴结局。PGT单胎妊娠的极低出生体重、<34周、<32周和<28周早产风险显著低于IVF/ICSI单胎妊娠,PGT多胎妊娠<32周早产风险也显著降低;两组母婴结局风险在单胎和多胎妊娠中相当。但由于证据质量低和统计假设检验的挑战,无法得出决定性结论,需要更多高质量大样本随机对照试验验证。
要点
- PGT单胎妊娠极低出生体重风险低于IVF/ICSI单胎(RR 0.66)。
- PGT单胎妊娠<34周、<32周、<28周早产风险均低于IVF/ICSI单胎。
- PGT多胎妊娠<32周早产风险低于IVF/ICSI多胎(RR 0.62)。
核心结论
- 由于证据质量低和统计假设检验的挑战,无法得出决定性结论。
- 需要更多高质量、大样本、方法学严格的随机对照试验来验证这些发现。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Embase、Web of Science和Cochrane中央对照试验注册库,时间范围为1990年1月至2025年5月。
- 纳入分别报告单胎和多胎妊娠结局的随机对照试验和观察性研究。
- 共纳入42项研究,包括43 663例PGT病例和217 002例IVF/ICSI病例。
- 采用随机效应模型计算相对风险(RR)或标准化均数差(SMD)及95%置信区间(CI)。
主要发现
- PGT单胎妊娠极低出生体重风险显著低于IVF/ICSI单胎妊娠(RR 0.66;95% CI 0.58, 0.76)。
- PGT单胎妊娠<34周早产风险显著低于IVF/ICSI单胎妊娠(RR 0.79;95% CI 0.73, 0.86)。
- PGT单胎妊娠<32周早产风险显著低于IVF/ICSI单胎妊娠(RR 0.68;95% CI 0.52, 0.89)。
- PGT单胎妊娠<28周早产风险显著低于IVF/ICSI单胎妊娠(RR 0.59;95% CI 0.35, 0.99)。
- PGT多胎妊娠<32周早产风险显著低于IVF/ICSI多胎妊娠(RR 0.62;95% CI 0.45, 0.86)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据质量低。
- 统计假设检验存在挑战。
- 需要更多高质量、大样本、方法学严格的随机对照试验来验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Controversy persists over whether preimplantation genetic testing (PGT) increases adverse maternal and neonatal outcomes. OBJECTIVES: To quantify the risk of maternal and neonatal outcomes for singleton and multiple pregnancies conceived after PGT versus those conceived after IVF/ICSI. SEARCH STRATEGY: PubMed, Embase, Web of Science, and Cochrane Central Register of Controlled Trials were searched from January 1990 to May 2025. SELECTION CRITERIA: Randomised controlled trials (RCTs) and observational studies separately reporting outcomes in singleton and multiple pregnancies. DATA COLLECTION AND ANALYSIS: Random-effects models were used for calculating relative risks (RRs) or standardised mean differences (SMDs) with 95% confidence intervals (CIs). MAIN RESULTS: Forty-two studies (43 663 PGT cases and 217 002 IVF/ICSI cases) were included for further analysis. The risks of very low birth weight (VLBW) (RR 0.66; 95% CI 0.58, 0.76), preterm birth (PTB) < 34 weeks (RR 0.79; 95% CI 0.73, 0.86), PTB < 32 weeks (RR 0.68; 95% CI 0.52, 0.89), and PTB < 28 weeks (RR 0.59; 95% CI 0.35, 0.99) in PGT singleton pregnancies were significantly lower than those in IVF/ICSI singleton pregnancies, and the risk of PTB < 32 weeks (RR 0.62; 95% CI 0.45, 0.86) in PGT multiple pregnancies was notably reduced compared to that in IVF/ICSI multiple pregnancies. The two groups showed comparable maternal outcome risks in singleton and multiple pregnancies. CONCLUSIONS: Nonetheless, no decisive conclusions can be drawn due to the low quality of evidence and challenges of statistical hypothesis testing. Additional high-quality RCTs with larger sample sizes and stringent methodologies are warranted to validate these findings.
引用
- Luo R, Zhao Q, Wang J, et al. Association of Preimplantation Genetic Testing With Maternal and Neonatal Outcomes in Singleton and Multiple Pregnancies: A Systematic Review and Meta-Analysis. BJOG. 2025. PMID: 40654038. doi:10.1111/1471-0528.18280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。